Contents hide 1 Cholangiocarcinoma 2 Myeloid or Lymphoid Neoplasms Pemigatinib is a type of targeted cancer drug. It is a treatment for bile duct cancer that has come back or spread to other parts of the body. This is advanced bile duct cancer. called Fibroblast Growth Factor Receptor 2 (FGFR2). Cholangiocarcinoma Indicated for unresectable locally advanced or metastatic cholangiocarcinoma in previously treated patients with a fibroblast growth factor receptor 2 (FGFR2) fusion or other rearrangement Each cycle is 21 days 13.5 mg PO qDay for 14 consecutive days followed by 7 days off therapy Continue until disease progression or unacceptable toxicity occurs … Continue reading Generic (Pemigatinib) PEMIDX